These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30903769)

  • 1. Changes in pentraxin-3 level and its interaction with metabolic indices in patients with coronary artery disease and type 2 diabetes mellitus.
    Kravchun PG; Kadykova OI; Molotyagin DG
    Wiad Lek; 2019; 72(2):181-185. PubMed ID: 30903769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
    J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
    Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cystatin-C and pentraxin-3 in coronary atherosclerosis.
    Doganer YC; Aydogan U; Aparci M; Nerkiz P; Barcin C; Cayci T; Sari O
    Coron Artery Dis; 2014 Nov; 25(7):589-94. PubMed ID: 24979323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.
    Uzun S; Ozari M; Gursu M; Karadag S; Behlul A; Sari S; Koldas M; Demir S; Karaali Z; Ozturk S
    Ren Fail; 2016 Sep; 38(8):1193-8. PubMed ID: 27436699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris.
    Morishita T; Uzui H; Nakano A; Fukuoka Y; Ikeda H; Amaya N; Kaseno K; Ishida K; Lee JD; Tada H
    Heart Vessels; 2018 Nov; 33(11):1301-1310. PubMed ID: 29789902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis.
    Nerkiz P; Doganer YC; Aydogan U; Akbulut H; Parlak A; Aydogdu A; Sari O; Cayci T; Barcin C; Koc B
    Med Princ Pract; 2015; 24(4):369-75. PubMed ID: 25969183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Plasma Pentraxin-3 Levels with Retinopathy and Systemic Factors in Diabetic Patients.
    Erdenen F; Güngel H; Altunoğlu E; Şak D; Müderrisoğlu C; Koro A; Akça Güler P; Hakan Sahin ME; Simsek G; Uzun H
    Metab Syndr Relat Disord; 2018 Sep; 16(7):358-365. PubMed ID: 30036122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
    Shahid HS; Kurdi MI; Zohair AA
    Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2].
    Koshelskaya OA; Kharitonova OA; Kologrivova IV; Suslova TE; Margolis NY; Tereshenkova EK; Rybina AN; Karpov RS
    Ter Arkh; 2021 Sep; 93(9):1030-1036. PubMed ID: 36286861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.
    Kanbay M; Ikizek M; Solak Y; Selcoki Y; Uysal S; Armutcu F; Eryonucu B; Covic A; Johnson RJ
    Am J Nephrol; 2011; 33(4):325-31. PubMed ID: 21389698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors?
    Nakamura A; Miura S; Shiga Y; Norimatsu K; Miyase Y; Suematsu Y; Mitsutake R; Saku K
    Heart Vessels; 2015 Nov; 30(6):752-61. PubMed ID: 25048680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulation levels of acute phase proteins pentraxin 3 and serum amyloid A in atherosclerosis have correlations with periodontal inflamed surface area.
    Temelli B; Yetkin Ay Z; Savaş HB; Aksoy F; Kumbul Doğuç D; Uskun E; Varol E
    J Appl Oral Sci; 2018; 26():e20170322. PubMed ID: 29742255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
    Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
    Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentraxin-3 in coronary artery disease: A meta-analysis.
    Chu Y; Teng J; Feng P; Liu H; Wang F; Li X
    Cytokine; 2019 Jul; 119():197-201. PubMed ID: 30954865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease.
    Schaan BD; Quadros AS; Sarmento-Leite R; De Lucca G; Bender A; Bertoluci M
    Cardiovasc Diabetol; 2007 Jul; 6():19. PubMed ID: 17651487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
    Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis.
    Hollan I; Nebuloni M; Bottazzi B; Mikkelsen K; Førre OT; Almdahl SM; Mantovani A; Fagerland MW; Aukrust P; Meroni PL;
    Cardiovasc Pathol; 2013; 22(5):324-31. PubMed ID: 23434196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.